Published in Acta Biomater on February 16, 2017
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. PLoS One (2017) 0.75
Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med (2017) 0.75
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Alternative activation of macrophages: mechanism and functions. Immunity (2010) 12.43
Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol (2006) 12.29
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science (2011) 8.53
Foreign body reaction to biomaterials. Semin Immunol (2007) 8.32
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol (2007) 7.80
Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 7.55
Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 6.96
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol (2007) 5.83
The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 4.97
Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol (2006) 4.87
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst (2014) 4.20
An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest (2011) 3.69
Neutrophil function: from mechanisms to disease. Annu Rev Immunol (2012) 3.63
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A (2010) 3.60
The sterile inflammatory response. Annu Rev Immunol (2010) 3.45
Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost (2012) 3.39
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem (2007) 3.28
Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol (2002) 3.23
Resolvins and protectins in inflammation resolution. Chem Rev (2011) 3.09
Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med (2015) 2.83
Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol (2003) 2.35
Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol (2008) 2.32
Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol (2008) 2.16
Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med (2013) 2.13
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res (2004) 2.12
Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity (2013) 2.08
The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials (2014) 2.04
Resolution of inflammation: an integrated view. EMBO Mol Med (2013) 2.01
Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol (2011) 1.95
A calculated response: control of inflammation by the innate immune system. J Clin Invest (2008) 1.93
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater (2015) 1.90
Molecular basis of biomaterial-mediated foreign body reactions. Blood (2001) 1.87
Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol (2013) 1.80
Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis (2009) 1.68
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J Immunol (2011) 1.52
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol (2012) 1.48
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47
Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab (2013) 1.45
Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials (2010) 1.33
Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A (2013) 1.33
Drug delivery systems: An updated review. Int J Pharm Investig (2012) 1.31
Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp Cell Res (2008) 1.29
Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta (2012) 1.27
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc Natl Acad Sci U S A (2013) 1.27
Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials (2012) 1.20
New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation. Front Immunol (2012) 1.20
On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells. J Exp Med (2013) 1.14
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J (2013) 1.12
Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc Natl Acad Sci U S A (2013) 1.08
Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials (2014) 1.06
Resolvins and protectins: natural pharmacophores for resolution biology. Prostaglandins Leukot Essent Fatty Acids (2010) 1.05
Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Front Immunol (2012) 1.05
Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res (2010) 1.04
Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets (2009) 1.02
Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost (2013) 1.01
Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood (2015) 0.98
Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth. Tissue Eng Part A (2010) 0.96
The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials (2013) 0.96
Neutrophils and Wound Repair: Positive Actions and Negative Reactions. Adv Wound Care (New Rochelle) (2013) 0.95
Small molecule inducers of angiogenesis for tissue engineering. Tissue Eng (2006) 0.92
Pretreatment neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev (2014) 0.91
Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres. Biomaterials (2012) 0.91
Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation. Cell Tissue Res (2011) 0.88
Neutrophil to lymphocyte ratio as a predictor of long-term mortality in African Americans undergoing percutaneous coronary intervention. Clin Cardiol (2009) 0.87
Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. Toxicol Appl Pharmacol (2014) 0.87
Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer. Oncol Lett (2015) 0.86
Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning. Acta Biomater (2014) 0.84
Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling. Biomaterials (2015) 0.83
Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect. J Biomed Mater Res A (2013) 0.83
Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med (2016) 0.82
Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with non ST-elevated acute coronary syndrome. Pak J Med Sci (2015) 0.82
Development of an immunomodulatory biomaterial: using resolvin D1 to modulate inflammation. Biomaterials (2015) 0.82
Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model. Arterioscler Thromb Vasc Biol (2014) 0.82
Gender-specific transfusion affects tumor-associated neutrophil: macrophage ratios in murine pancreatic adenocarcinoma. J Gastrointest Surg (2010) 0.81
Controlled release of cytokines using silk-biomaterials for macrophage polarization. Biomaterials (2015) 0.80
Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules. PLoS One (2015) 0.80
The molecular mechanisms of chronic inflammation development. Front Immunol (2012) 0.79
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. J Vasc Surg (2016) 0.79
Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design. Exp Biol Med (Maywood) (2016) 0.75
Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation. Circulation (2016) 0.75
Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. J Biomed Mater Res A (2016) 0.75
Selective recruitment of non-classical monocytes promotes skeletal muscle repair. Biomaterials (2016) 0.77